Publicceoboardbriefing
Total Page:16
File Type:pdf, Size:1020Kb
Sheffield Teaching Hospitals NHS Foundation Trust Chief Executive’s Briefing Board of Directors – 25 May 2021 1. Covid-19 Gold Update As the Covid-19 pandemic continues, the Trust is focused on safely providing urgent and emergency services and high levels of planned elective care. With the easing of the national restrictions, the Trust is working with local and national partners to ensure the reset of services remains effective and enables holistic patient centred care. An update on the current position and next steps will be provided in the meeting. 2. Integrated Performance Report For the Integrated Performance Report (paper Dii), each Director will highlight the key issues for the Board of Directors. 3. Clinical Director - Urology I am pleased to announce that Mr David Smith has been appointed as Clinical Director for Urology. David will take up the Clinical Director post from 1 June 2021. I would like to thank Mr Richard Inman for his contribution to Urology and the wider organisation during his time as Clinical Director. 4. Cancer Prehabilitation and Rehabilitation Programme The Advanced Wellbeing Research Centre (AWRC) at Sheffield Hallam University, Yorkshire Cancer Research and Sheffield Teaching Hospitals are working together to support people affected by cancer in Sheffield through a new prehabilitation and rehabilitation service. By providing access to physical activity, nutritional optimisation and psychological support, the service aims to help people with cancer prepare for and recover from treatment (surgery, chemotherapy and radiotherapy) and maintain healthy lifestyles after their cancer diagnosis. This initiative is currently in the mobilisation phase with a plan to start receiving referrals in Autumn 2021. The name of the service is yet to be agreed. 5. Hadfield Update The rectification works on the Hadfield Building were completed in early May and the Trust received a letter from South Yorkshire Fire and Rescue Authority on 7 May 2021 following an onsite inspection. I am delighted to confirm that the Prohibition Notice was withdrawn. Final commissioning and cleaning work has been ongoing since then and there will be a phased reoccupation of the ward accommodation starting on 5 - 6 June 2021 and completing on 3 - 4 July 2021. 1 6. Regulation 28 – Laura Booth Following the inquest into the sad death of Laura Booth in October 2016, the Trust has received a Prevention of Future Deaths (Regulation 28) Report from Her Majesty’s Coroner. In this report the Coroner highlights issues relating to Laura’s nutritional care, but acknowledges the changes we have made to our nutrition services and processes to ensure appropriate support for patients with complex nutritional needs. The Coroner does however also highlight concerns relating to our application of the Mental Capacity Act, in particular staff awareness of the requirements and the steps needed to ensure patients and families are fully involved in decisions about care and treatment. Prior to receipt of the Coroner’s report, we had completed a review of our Mental Capacity Act training and the revised programme was launched in early May 2021. Work is now in progress to identify what further actions are required in light of the Coroner’s findings. We will be responding to all of the Coroner’s recommendations and are required to do so by 4 July 2021. 7. EU Settlement Scheme – Application Deadline 30 June 2021 As part of the EU transition arrangements, all EU, EEA or Swiss citizens resident in the UK by 31 December 2020 and their family members need to apply to the EU Settlement Scheme to continue living, working and accessing public services in the UK beyond the application deadline of 30 June 2021. There are currently just over 340 EU, EEA or Swiss nationals employed at the Trust across a range of roles and specialisms. There are likely to be a number of these staff who have already applied for settled status but as employers we are unable to request this information until after the June deadline - unless staff choose to provide this information voluntarily it is not currently possible to determine how many have settled status or not. We have been engaging with and informing our workforce regarding the EU Settlement Scheme and the steps they need to take. This began in summer 2019 and will continue until the end of June deadline. This engagement includes: • Detailed legal briefings with Q&A session run by specialist immigration lawyer – August 2019 and April 2021, the second of which I hosted. • Individual letters sent to EU staff • Trustwide Communications Update/Social media to highlight key information/dates and signpost to Gov.uk resources • Updates to the Trust’s Human Resources intranet page to provide current information on the scheme and signpost to the Gov.uk website to apply • Official posters and leaflets displayed in staff areas/dining rooms and provided to areas where staff don’t have ready access to email or online communication channels • Localised communication approaches linking in with Trust managers and staff side colleagues for distribution via UNISON communication routes 8. Strategy Development As the Board is aware, work to develop a new corporate strategy is underway and will be shared in due course. In considering the framework for this strategy, TEG received a proposal to adopt a new strategic aim associated with sustainability and responding to the climate emergency. TEG was supportive of this approach and the strategy will be developed to incorporate this. 2 9. Communications and Awards Update I am delighted to let you know that a number of our teams and staff have been recognised for excellence in their field in the last month. • Six of our nurses have been honoured by the Chief Nurse of England, Ruth May, with Gold and Silver awards, recognising their major contribution to patient care. Catherine Bailey, Nurse Director for the Musculo-Skeletal Care Group was awarded the Chief Nursing Officer for England’s Gold Award. The prestigious Gold Award was awarded to Catherine for her exceptional standards of clinical practice and leadership during her distinguished career which spans over 40 years. Five Silver Awards were also presented to staff across the Trust in honour of their excellence in clinical practice, patient care and contributions to the profession. Kirsten Clinton, Nurse Consultant for Accident and Emergency Medicine, Anna Philipose, Sister for Medicine and Pharmacy Services, Jane Coates, Matron for Neurosurgery, Neuro Critical Care and Neuro Rehabilitation, Ruth Ostrovskis- Wilkes, Senior Sister for SYRS, and Karen Jessop, Deputy Chief Nurse at the Trust all received their awards during a virtual ceremony with Ruth May. • Professor John Snowden has been elected as President of the British Society of Blood and Marrow Transplantation and Cellular Therapy. He will hold this role until December 2022, which will see him use his significant experience and expertise in improving outcomes for patients undergoing bone marrow or stem cell transplantations. He was elected into the role by members of the professional society. • Dr Josh Wright has been elected as Vice President of the British Society of Haematology, a national society dedicated to helping members support people with blood disorders and diseases. He will take up the Presidency role from 2022 onwards. • The NIHR have awarded £1.8m to Mr Mostafa Metwally, Consultant Gynaecologist and Sub-specialist in Reproductive Medicine and Surgery to lead a study evaluating if pregnancy success rates are improved by removing small fibroids and endometrial polyps in the womb. The award is given to Mr Metwally and the University of Sheffield’s Clinical Trials Unit through the NIHR’s Health Technology Assessment programme. • Professor Mark McAlindon has been named a finalist in the Royal College of Physicians’ Excellence in Patient Care Awards Innovation category for his team’s work in pioneering minimally invasive endoscopy, including capsule endoscopy, double balloon enteroscopy, and most recently research identifying methods using magnets to examine the upper GI tract, with Sheffield becoming the first centre to use a robot- controlled magnetic capsule system outside China in 2016. The winners will be announced later this month. • Professor Jaydip Ray and a team of scientists from the University of Sheffield won first prize at the Royal Society of Medicine’s Off the Beaten Track session after becoming one of only a handful of research teams over the past decade to restore function in the delicate organs of the inner ear which control balance. The research, which was undertaken in mice, is one of only a handful in the world to successfully use vestibular implants in a proof of concept study over the past decade, and could pave the way for the technology to be used in humans, once shown to be safe and effective, in many years to come. The Royal Society of Medicine’s highly competitive Off the Beaten track awards promote exceptional scientific achievement and innovation. 3 • Professor Alan Lobo, Consultant Gastroenterologist at the Trust is to lead a £450,000 study seeking to understand what matters to patients who live with inflammatory bowel disease, a lifelong chronic condition. The study will put patients, who have limited opportunities to express what is important to them despite advances in treatment being rapid in recent years, at the heart of care so that the ongoing debilitating effects of the condition can be better met by healthcare professionals when they seek care. • Imran Aziz has been awarded the United European Gastroenterology (UEG) Rising Star Award 2021 for his excellent academic track record and ongoing high calibre work within the field of functional gastrointestinal disorders, such as irritable bowel syndrome. He will present his work at the Your Rising Star presentation at UEG Week Virtual 2021 which will be held from October 2 – 6, 2021.